SCHEMBL12873188

SCHEMBL12873188

Cn1c2ccccc2c2cc3c(-c4ccc5ccccc5c4)c4cc(N(c5ccccc5)c5ccccc5)ccc4c(-c4ccc5ccccc5c4)c3cc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.39
▸ MAPT P10636 4/20 0.39
▸ ALDH1A1 P00352 3/20 0.39
▸ HPGD P15428 3/20 0.39
▸ L3MBTL1 Q9Y468 3/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ PABPC1 P11940 1/20 0.36
▸ GPR3 P46089 1/20 0.36
▸ KIF11 P52732 1/20 0.35
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 3/20 0.33
▸ LMNA P02545 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13291217 0.89 KMT2A (0.40) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL12703017 0.87 KDM4E (0.49) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL23660606 0.86 KDM4E (0.46) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL12873191 0.86 KDM4E (0.39) KDM4EL3MBTL1KMT2ATUBB4ATUBB
SCHEMBL18565019 0.86 KDM4E (0.48) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL14362633 0.86 GPR3 (0.46) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL12873195 0.86 KDM4E (0.50) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL14521297 0.84 KDM4E (0.44) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL8406128 0.84 GPR84 (0.37) KDM4EMAPTALDH1A1HPGDL3MBTL1
SCHEMBL12928339 0.84 GPR84 (0.37) KDM4EMAPTALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2662356-B1 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO LTD (KR) 2016-10-12 — — EP disclosed
US-9045419-B2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-02 — — US disclosed
US-9045419-B2 Condensed-cyclic compound and organic light emitting diode having organic layer including the same SAMSUNG DISPLAY CO., LTD. (KR) 2015-06-02 — — US disclosed
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-02-10 — — US disclosed
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2011-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110031484-A1 CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DIODE HAVING ORGANIC LAYER INCLUDING THE SAME CRY1, CCNL2, CCNT1 KDM4E 3376/4885MAPT 955/4885ALDH1A1 153/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback